Gsk Share Discussion Threads

[tradermichael] 03/6/2024 11:14

So, since this is a procedural statement, NOT a judgement, nothing new in this information as far as legislative proceedings or outcome. What does due diligence tell us about any outcome that could go against GSK and the potential impact on the share price? Some would say that its "already in the price"!

[supermarky] 03/6/2024 11:11

i am just holding and not topping up.

[ny boy] 03/6/2024 11:09

Have reviewed ny earlier position and carried out some due diligence, it seems 10% drop is pretty harsh, if there are dip buyers around then you might see a gentle recovery to around 1650-1700p area. DYOR as usual

[tradermichael] 03/6/2024 11:08

IN @1607p ..... ;0)

[supermarky] 03/6/2024 10:31

is this suddenly an aim stock?

[tsmith2] 03/6/2024 10:17

opportune?

[abdullla] 03/6/2024 09:27

From the twisted order book !

[tradermichael] 03/6/2024 09:03

Not more sellers today compared to normal,,,, so where does this price drop come from??

[montyhedge] 03/6/2024 09:01

Wtf happened here? Why ?

[pj fozzie] 03/6/2024 08:58

"Nothing out there proves a link between zantac and cancer." - and there's a very similar line that's been quoted by the tobacco companies for decades ....

[igoe104] 03/6/2024 08:46

Nothing out there proves a link between zantac and cancer..

[tradermichael] 03/6/2024 08:36

Again, this is procedural news, NOT a judgement

[laurence llewelyn binliner] 03/6/2024 08:30

RKT tanked -27% from GBP58 to 42 on the Infamil court case ruling, but is now recovering to 45 currently..

-10% is ugly, but we got away lightly in comparison, and a could be a gift for long term income seeking holders at GBP16..

[supermarky] 03/6/2024 08:27

yawn wait until the dust settles

[supermarky] 03/6/2024 08:26

so a massive company like gsk is suddenly worth 10% less on a whisper.

[ny boy] 03/6/2024 08:26

Avoid after a trap door event, usually more problems and drops ahead imo

[supermarky] 03/6/2024 08:25

Markets can be crazy. Hold and chill.

[tradermichael] 03/6/2024 08:21

This is procedural news, NOT a judgement

[waldron] 03/6/2024 08:21

GSK Plans Appeal Against US Judge's Ruling on Jury Trials for Zantac Cases
June 03, 2024 at 02:58 am EDT
Share
(MT Newswires) -- GSK (GSK.L) said Monday it will immediately seek an appeal after a US state court judge agreed that plaintiffs' scientific evidence could be heard in jury trials involving the heartburn drug Zantac and its alleged link to cancer.

Judge Vivian Medinilla of the Delaware State Court said "it would be improper to simply dismiss these experts as 'poseurs or witnesses for hire', London's Financial Times reported June 1.

The British pharmaceutical company said the recent decision contradicts the federal court's multidistrict litigation ruling in December 2022. It then highlighted the scientific consensus regarding the lack of consistent or reliable evidence that the medication increases the risk of any cancer.

GSK noted that the US judge's verdict does not mean the court agrees with the scientific conclusions of the plaintiffs' experts nor does it mean liability.

In addition to GSK, pharmaceutical companies that marketed the drug including Sanofi (SAN.PA), Boehringer Ingelheim and Pfizer (PFE.F) are facing similar lawsuits related to Zantac.

[alibizzle] 03/6/2024 08:13

I'm pleased I sold all my baleon and GSK shares 2 weeks ago after 2 years of misery , for a £300 profit after being over £16k down after xantac collapse . Will invest in ISA and now no longer need to check share price daily . Good luck to all

[rikky72] 03/6/2024 08:12

Like scared rabbits.. idiots!